Markets:

Overview

News

Currencies

International

Treasuries

Incyte Corporation - Common Stock (NQ:INCY)

99.67 -1.41 (-1.39%)

Streaming Delayed Price Updated: 3:20 PM EST, Jan 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Incyte Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

25 26 Next >

Which S&P500 stocks are gapping on Wednesday? ↗

October 08, 2025

Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Wednesday to uncover the stocks that are gapping in the S&P500 index.

Via Chartmill

Incyte to Report Third Quarter Financial Results

October 08, 2025

From Incyte

Via Business Wire

2 Reasons to Like INCY and 1 to Stay Skeptical

October 02, 2025

Incyte has had an impressive run over the past six months as its shares have beaten the S&P 500 by 19.6%. The stock now trades at $86.01, marking a 38% gain. This was partly due to its solid quarterly...

Via StockStory

Topics Stocks

Merus N.V. Soars on $8 Billion Genmab Acquisition, Propelled by Oncology Pipeline Successes

September 29, 2025

Merus N.V. (NASDAQ: MRUS) has become the undisputed top performer in today's market, with its stock price rocketing by an astounding 35.9% following the bombshell announcement of its acquisition by...

Via MarketMinute

13 Analysts Have This To Say About Incyte ↗

August 22, 2025

Via Benzinga

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

September 24, 2025

From Incyte

Via Business Wire

STRATA Skin Sciences Soars as Landmark Study Reveals Superior Vitiligo Treatment Efficacy

September 23, 2025

STRATA Skin Sciences Inc. (NASDAQ: SSKN) witnessed a dramatic surge in its stock price today, climbing 51.18% following the publication of a groundbreaking peer-reviewed study. The research highlights...

Via MarketMinute

Topics Intellectual Property

Jim Cramer Spotlights These Undervalued S&P 500 Stocks With Growth Potential Amid Skyrocketing Market ↗

September 23, 2025

In a recent episode of "Mad Money," Jim Cramer identified several stocks in the S&P 500 that he believes are undervalued, offering growth potential despite the market's record highs.

Via Benzinga

Topics Stocks

Incyte Announces the Appointment of Dave Gardner as Executive Vice President and Chief Strategy Officer

September 22, 2025

From Incyte

Via Business Wire

Incyte Stock: A Deep Dive Into Analyst Perspectives (11 Ratings) ↗

September 19, 2025

Via Benzinga

FDA Expands Incyte's Opzelura Approval To Treat Atopic Dermatitis In Children ↗

September 19, 2025

FDA approves Incyte's Opzelura cream for children aged two and older with atopic dermatitis, expanding its use beyond teens and adults.

Via Benzinga

Incyte Corp (NASDAQ:INCY) Emerges as a Top Value Investing Candidate ↗

September 19, 2025

Incyte Corp (INCY) presents a strong value investing case with low P/E ratios, robust financial health, and high profitability in the biotech sector.

Via Chartmill

Incyte Announces Additional FDA Approval of Opzelura® (Ruxolitinib) Cream in Children Ages 2-11 with Atopic Dermatitis

September 18, 2025

From Incyte

Via Business Wire

Incyte Announces New 24-Week Phase 3 Data from the STOP-HS Clinical Trial Program of Povorcitinib in Hidradenitis Suppurativa at EADV 2025

September 17, 2025

From Incyte

Via Business Wire

2 S&P 500 Stocks with Exciting Potential and 1 We Avoid

September 15, 2025

The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some...

Via StockStory

Topics Stocks

Uncover the latest developments among S&P500 stocks in today's session. ↗

September 12, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

September 12, 2025

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

Via StockStory

Incyte to Present New Data Highlighting Progress Across its Dermatology Pipeline at the European Association of Dermatology and Venerology 2025 Congress

September 10, 2025

From Incyte

Via Business Wire

Incyte Launches HS TRUTHS to Spotlight the True Lived Experience of Hidradenitis Suppurativa

September 03, 2025

From Incyte

Via Business Wire

Incyte (INCY) Stock Is Up, What You Need To Know

September 02, 2025

Shares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) jumped 2.4% in the afternoon session after Barclays initiated coverage on the stock with an Overweight rating, helping the shares...

Via StockStory

Topics Economy

Tuesday's session: top gainers and losers in the S&P500 index ↗

September 02, 2025

Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday.

Via Chartmill

1 Profitable Stock to Keep an Eye On and 2 We Question

September 01, 2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my...

Via StockStory

Can Incyte Deliver on 447% EPS Forecasts and Pipeline Hype? ↗

August 29, 2025

Analysts expect nearly 450% EPS growth in 2025, making execution on its core portfolio critical for sustaining the outperformance experienced so far YTD.

Via MarketBeat

Incyte Corp (NASDAQ:INCY): A Prime Candidate for Value Investors Seeking Undervalued Stocks ↗

August 29, 2025

Discover Incyte Corp (INCY), an undervalued biotech stock with strong profitability, solid financial health, and promising growth potential for value investors.

Via Chartmill

Incyte Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

August 27, 2025

From Incyte

Via Business Wire

S&P 500 Losers: 22 Stocks With Negative Returns Over Past 10 Years, And This One's Getting The Boot ↗

August 26, 2025

The S&P 500 Index is up over 200% over the past decade, but 22 stocks have declined during that period, and one is set to be removed soon.

Via Benzinga

Topics Stocks

Incyte Announces the Appointment of Soni Basi as Executive Vice President and Chief Human Resources Officer

August 25, 2025

From Incyte

Via Business Wire

1 Mid-Cap Stock with Solid Fundamentals and 2 We Find Risky

August 25, 2025

Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract...

Via StockStory

2 Mooning Stocks with Exciting Potential and 1 We Ignore

August 22, 2025

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial...

Via StockStory

Incyte to Present at Upcoming Investor Conferences

August 19, 2025

From Incyte

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

25 26 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.